National Dangerous Drugs Control Board

What National Dangerous Drugs Control Board does

The National Dangerous Drugs Control Board (NDDCB) is a Sri Lankan statutory board established on 9 April 1984 under the National Dangerous Drugs Control Board Act No. 11 of 1984, designated as the principal national institution for formulation of drug-control policy and for treatment and rehabilitation of drug-dependent persons. Headquartered at 383 Kotte Road, Rajagiriya, NDDCB operates four residential treatment and rehabilitation centers (Talangama, Nawadiganthaya, Galle, and Kandy), the National Narcotics Laboratory for forensic drug analysis, a Drug Abuse Monitoring System for national prevalence and trend tracking, the Precursor Control Authority for licensing of precursor chemicals under the 2008 Conventions Act, and a 24/7 national helpline (1927). It also runs school-, youth-, family-, and community-based prevention education through the Preventive Education and Training Unit and the Outreach Unit, which extends coverage to 9 provinces and 18 districts. NDDCB monitors and certifies 11 designated prison treatment centers and 22+ private treatment centers, and produces annual drug-abuse handbooks and statistical reports through its Research Division.

NDDCB is wholly government-owned and funded through annual parliamentary appropriations, with no commercial revenue stream. Treatment services are delivered free or at minimal cost, and the private centers it licenses are fee-based but revenue accrues to those operators, not to NDDCB. Its technology footprint is operational and regulatory rather than commercial: a national drug trend database (DAMS), a UNODC-co-developed Computer Based Training e-learning program in Sinhala and English, a precursor chemical licensing system, and a helpline CRM. Strategic partnerships span UNODC (quality assurance and capacity building), WHO (data sharing), INCB (precursor control), SAARC, and UNDP. Leadership comprises a Chairman (retired DIG of Police J.A.K. Mark), Director General Commander (Rtd) K.K.S. Kothalawala, and directors across Administration, Treatment & Rehabilitation, and Research, supported by approximately 59 staff organization-wide.

Name

National Dangerous Drugs Control Board

Legal name

National Dangerous Drugs Control Board

Website

https://nddcb.gov.lk

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

51–100 employees

Short description

The National Dangerous Drugs Control Board is Sri Lanka's statutory national agency, established 1984, operating four drug treatment and rehabilitation centers, a forensic narcotics laboratory, a national drug-abuse monitoring system, and precursor chemical licensing to combat drug abuse across the country.

Ownership category

akta.pro rank

Product category

Public Health Drug Control Services

NAICS

Public Administration (92), Psychiatric and Substance Abuse Hospitals (622210), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Skilled Nursing Care Facilities (8051)

akta.pro primary industry

Controlled Substances & Narcotics Regulators (HLAJADAK)

akta.pro secondary industry

Substance Use, Addiction & Harm Reduction Health Departments (HLAJAAAM)

Keywords

• Drug control services
• Substance abuse treatment
• Rehabilitation programs
• Precursor chemical regulation
• Drug prevention education

Headquarters

HQ city

Rajagiriya

HQ country

Sri Lanka

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Others

Revenue model

1. Government Funding: NDDCB is a government institution funded through the Sri Lanka government budget. Revenue comes from annual parliamentary appropriations for operational expenses, treatment services, and national drug control programs.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

NDDCB is Sri Lanka's national government authority responsible for drug prevention, treatment, rehabilitation, and precursor chemical regulation. It operates four government-run residential treatment and rehabilitation centers, provides forensic laboratory services through the National Narcotics Laboratory, monitors national drug abuse trends via the Drug Abuse Monitoring System, regulates precursor chemicals through the Precursor Control Authority, runs a 24/7 helpline (1927), and delivers prevention education programs across schools, communities, and youth populations.

Product overview

National Dangerous Drugs Control Board operates as a government agency offering a portfolio of interconnected drug control services centered around prevention, treatment, and rehabilitation. The core offerings include four residential treatment and rehabilitation centers (Talangama, Nawadiganthaya, Galle, Kandy), the National Narcotics Laboratory for forensic analysis, the Drug Abuse Monitoring System for trend tracking, the Precursor Control Authority for regulatory licensing, the 1927 Helpline for crisis support, and Preventive Education and Training programs spanning school, youth, family, and community levels. Supporting services include outreach units, designated/private treatment center monitoring, certificate courses in drug counselling and prevention, and research publications including the annual handbook and statistical reports.

Differentiator

Problem solved

Functional benefit

Products and services

• Treatment and Rehabilitation Services Residential and outpatient treatment programs for drug-dependent persons, including counseling, therapy, vocational training, and aftercare support, conducted at four NDDCB centers across Sri Lanka (Talangama, Nawadiganthaya, Galle, Kandy).
• National Narcotics Laboratory (NNL) Services Laboratory providing scientific and forensic analysis services for drug identification, biological specimen testing (urine testing), drug detection test kits, and scientific evidence for law enforcement agencies and court proceedings.
• Drug Abuse Monitoring System (DAMS) National surveillance system to determine incidences, prevalence, and characteristics of drug-dependent persons, monitor trends and patterns of drug abuse, identify at-risk groups, and implement early warning systems.
• 1927 National Helpline 24-hour telephone helpline service providing counseling and support for individuals and families affected by drug abuse, along with referrals to treatment services.
• Preventive Education and Training Programs

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• United Nations Office on Drugs and Crime (UNODC)coreStrategic or Co-development PartnerUNODC collaborates with NDDCB on international quality assurance programs for the National Narcotics Laboratory, capacity building for drug law enforcement, and development of computer-based training programs. The partnership supports Sri Lanka's compliance with international drug control conventions.
• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO receives drug abuse information and statistics from NDDCB as part of international drug monitoring systems. NDDCB provides data for global drug trend analysis and policy development.
• SAARC (South Asian Association for Regional Cooperation)minorStrategic or Co-development PartnerNDDCB participates in SAARC drug control activities and shares drug abuse information with SAARC as part of regional cooperation on narcotic drugs and psychotropic substances.
• UNDP (United Nations Development Programme)minorStrategic or Co-development PartnerNDDCB collaborates with UNDP on drug control activities and receives support for policy development and implementation.
• International Narcotics Control Board (INCB)coreStrategic or Co-development PartnerINCB coordinates with NDDCB on precursor chemical control, pre-export notifications, and Sri Lanka's compliance with 1988 UN Convention on drug trafficking. NDDCB furnishes reports and returns to INCB.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• International Narcotics Control Board (INCB): UN body monitoring compliance with international drug conventions. NDDCB reports precursor control data to INCB — comparable as the upstream treaty-compliance authority shaping NDDCB's regulatory obligations.
• United Nations Office on Drugs and Crime (UNODC): UN entity setting global drug control standards. NDDCB partners with UNODC for laboratory QA, training, and CBT development — comparable as the upstream policy/standards authority that NDDCB's programs align with.

Direct peers

• NACADA (National Authority for the Campaign Against Alcohol and Drug Abuse, Kenya): Kenya's statutory agency for coordinating national drug and substance abuse policy, treatment, prevention, and rehabilitation. Comparable as a national focal point integrating prevention, treatment, and regulatory functions in a single authority.
• Narcotics Control Bureau (NCB India): India's national narcotics law enforcement and coordination agency. Directly comparable as a South Asian statutory drug control authority handling precursor regulation, treatment coordination, and international compliance reporting.
• Philippine Drug Enforcement Agency (PDEA): Philippines' lead anti-drug agency under the Office of the President. Comparable as a national authority combining law enforcement, prevention, treatment referral, and rehabilitation oversight.
• Central Narcotics Bureau (CNB Singapore): Singapore's national drug control authority. Comparable in statutory mandate covering drug enforcement, prevention education, rehabilitation coordination, and laboratory drug analysis within a single national framework.
• Office of the Narcotics Control Board (ONCB Thailand): Thailand's national drug control agency under the Prime Minister's Office. Comparable as a regional peer combining drug suppression, prevention, treatment referral, and demand-reduction programming through a centralized national body.

Broad incumbents

• SICAD (General Directorate for Intervention on Addictive Behaviours and Dependencies, Portugal): Portugal's national coordinating body for drug policy, prevention, treatment, and harm reduction. Comparable as a comprehensive national authority combining regulatory, prevention, and treatment coordination roles.
• Drug Enforcement Administration (DEA): U.S. federal drug enforcement agency. Operates at much greater scale but covers the same core functions of narcotics regulation, forensic laboratory services, and precursor chemical control relevant to NDDCB's mandate.

Regional players

• Department of Narcotics Control (DNC Bangladesh): Bangladesh's national department responsible for drug control including precursor regulation, treatment oversight, and demand reduction. Comparable South Asian peer with similar integrated drug control mandate.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nddcb
• YouTubeyoutube.com/user/nddcb
• Facebookfacebook.com/nddcblk
• Instagraminstagram.com/nddcblk
• LinkedInlinkedin.com/company/national-dangerous-drugs-control-board

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Dangerous Drugs Control Board